Maximize the chances of identifying molecularly matched therapies

Driven by targeted molecular therapies and immunotherapies, precision medicine offers an individualized approach that battles cancer at its core—the genome. As new oncogenic drivers are uncovered at an unprecedented rate, a testing method that can keep pace is needed. One method meeting this challenge is comprehensive genomic profiling, or CGP.

Explore this e-book by Illumina to enable precision medicine with comprehensive genomic profiling

Fill out the form to access content

Name

Last Name

Number

Job Title *

Company Name

Address

City

State

Zipcode

Country

Can an Illumina representative contact you?

Yes No

I consent to Illumina processing my personal information to communicate with me for marketing purposes in accordance with their Privacy Policy .

Yes No

By submitting this form, you consent to the collection and sharing of your contact details so we can respond to your inquiry and send relevant updates from illumina, including information on products, services, and events. Your data will be processed in Canada and then securely transferred to illumina, which will manage your information and handle any opt-out or removal requests. For details on how your data is used and protected, please review our Terms of Use and our Privacy, Opt-out, and Information Removal policies below.